Table 1

Patient characteristics

CharacteristicsOverall
(n=726)
LAA thrombus*P value
Positive
(n=57)
Negative
(n=669)
Age, year61±1164±1061±110.129
Male437 (60.2)36 (63.2)401 (59.9)0.634
Paroxysmal AF436 (60.1)30 (52.6)406 (60.7)0.233
AF course, month42±8339±4543±850.540
CHA2DS2-VASc score2±23±22±20.089
Congestive heart failure116 (16.0)18 (31.6)98 (14.6)0.001
Hypertension346 (47.7)25 (43.9)321 (48.0)0.550
Diabetes mellitus107 (14.7)10 (17.5)97 (14.5)0.534
Previous stroke/TIA91 (12.5)14 (24.6)77 (11.5)0.004
Vascular disease292 (40.2)22 (38.6)270 (40.4)0.795
LAAPD, mm36±741±936±7<0.001
LVEDD, mm46±549±746±50.006
LVEF, %60±856±1160±70.005
 Complex LAA morphology289 (39.8)35 (61.4)254 (38.0)0.001
 CCT results
 Filling defects43 (5.9)39 (68.4)4 (0.6)<0.001
 No filling defects683 (94.1)18 (31.6)665 (99.4)
  • Values are mean±SD or n (%).

  • *The thrombi were detected using the TEE.

  • AF, atrial fibrillation; CCT, cardiac CT; CHA2DS2-VASc, congestive heart failure, hypertension, age ≥75 years (doubled), diabetes, previous stroke/TIA/thromboembolism (doubled), vascular disease, age 65–74 years and sex category (female); LAA, left atrial appendage; LAAPD, left atrial anterior-posterior diameter; LVEDD, left ventricular end-diastolic diameter; LVEF, left ventricular ejection fraction; TEE, trans-oesophageal echocardiography; TIA, transient ischaemic attack.